Puma Biotechnology, Inc.
NASDAQ: PBYI
$7.35
-$0.02 (-0.3%)
Closing price April 2, 2020
Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the 2019 San Antonio Breast Cancer...
3 months ago
Last Updated: 2 months ago
Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade Desk and Yext.
3 months ago
Last Updated: 2 months ago
Tuesday's top analyst upgrades, downgrades and initiations included Apollo Global Management, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target and TJX Companies.
5 months ago
Last Updated: 2 months ago
Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off from this FDA sugar high.
6 months ago
Last Updated: 2 months ago
Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see numerous waves of selling in...
1 year ago
Last Updated: 2 months ago
General Electric, Encana Energy, Puma Biotechnology, and Kraft Heinz all posted new 52-week lows Friday.
1 year ago
Last Updated: 2 months ago
Stocks were indicated to open higher on China trade deal hopes and after a stronger nonfarm payrolls report. While the stock market has bounced handily from the lows at the end of October,...
1 year ago
Last Updated: 2 months ago
Puma Biotechnology shares were climbing on Tuesday after the company announced that it expects a positive outcome in Europe.
1 year ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and other research calls from Friday included AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp and Sarepta Therapeutics.
1 year ago
Last Updated: 2 months ago
The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA approval for that drug. And the larger the drug target group is, the more exciting it...
1 year ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp and Southwest Airlines.
1 year ago
Last Updated: 2 months ago
Puma Biotechnology saw its shares take a dive on Wednesday following regulatory events in Europe for its breast cancer treatment.
2 years ago
Last Updated: 2 months ago
With 2017 nearing an end, it is important to consider just what has happened. 24/7 Wall St. has screened 50 stocks that have risen 100% or more (some far more) in 2017.
2 years ago
Last Updated: 2 months ago
Puma Biotechnology, Inc. (NASDAQ: PBYI) saw its shares touch a multiyear high on Tuesday after the firm reported a key approval by the U.S. Food and Drug Administration (FDA). Specifically, the...
2 years ago
Last Updated: 2 months ago
Stocks were indicated marginally lower on Tuesday, but the major equity indexes remain just under all-time highs. The bull market may now be well over eight years old, but investors keep proving that...
2 years ago
Last Updated: 2 months ago